Jonathan Milner

Investment Partner , Angel

Overview

Gender
male
Investor Type
Investment Partner,Angel
Investor Stage
Seed

Having worked in the life sciences industry for over ten years as an academic researcher, Jonathan identified the market opportunity for supplying high quality antibodies to support protein interaction studies and, in 1998, founded Abcam with David Cleevely and Professor Tony Kouzarides.

Jonathan is a Non-Executive Director of Horizon Discovery Group plc, The Evolution Education Trust, GeoSpock Ltd and Sydicate Room Group Ltd. He is also Chairman of Axol Bioscience Ltd, PhoreMost Ltd, Repositive Limited, Definigen Limited and Cambridge Allergy Ltd. Jonathan holds an executive director position at Meltwind Limited, being a designated member of Meltwind Advisory LLP.

Jonathan is an experienced entrepreneur and investor and is passionate about supporting UK life science and high-tech start-ups. He has provided considerable investment and support to over 30 companies and has assisted three AIM IPOs.

Personal Investments

Number of Investments
1
Jonathan Milner has made 1 investments. Their most recent investment was on Oct 6, 2021, when Bactobio raised $3.80M.
Date Company Name Round Money Raised Industry
Oct 6, 2021 Bactobio Seed $3.80M Biotechnology Detail

Jobs

Number of Current Jobs
1
Jonathan Milner has 1 current jobs including Member of Advisory Panel at Cambridge Innovation Capital , .
Organization Name Title At Company Start Date End Date
Cambridge Innovation Capital Member of Advisory Panel Detail